finafloxacin
Selected indexed studies
- Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. (Antibiotics (Basel), 2021) [PMID:34943718]
- Finafloxacin: first global approval. (Drugs, 2015) [PMID:25808831]
- Finafloxacin for the treatment of urinary tract infections. (Expert Opin Investig Drugs, 2015) [PMID:26068714]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. (2021) pubmed
- Finafloxacin: first global approval. (2015) pubmed
- Finafloxacin for the treatment of urinary tract infections. (2015) pubmed
- Efficacy of finafloxacin in a murine model of inhalational glanders. (2022) pubmed
- Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. (2020) pubmed
- In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens. (2023) pubmed
- Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection. (2021) pubmed
- In Vitro Activity of Delafloxacin and Finafloxacin against Mycoplasma hominis and Ureaplasma Species. (2022) pubmed
- Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers. (2017) pubmed
- Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance. (2017) pubmed